Micronoma
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6342 Ferris Sq, San Diego, California, 9...Phone Number
(858) 337-1326Website
www.micronoma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Micronoma
Founded in 2019 and headquartered in San Diego, California, Micronoma is a cancer-detection company that uses liquid biopsy technology to detect and predict cancers.Explore more
Micronoma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Micronoma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Micronoma is spiking on competitors!
Check if Micronoma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Micronoma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Micronoma launches new products
Micronoma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Micronoma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Micronoma
Website visits: Recent activity has been detected on your website
Click to see if Micronoma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Micronoma
Compare insights from companies similar to Micronoma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Micronoma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Micronoma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Micronoma.
Micronoma Tech Stack
A closer look at the technologies used by Micronoma
See more technologies
Micronoma News & Media
Micronoma Presents State-of-the-Art Metagenomic Liquid Biopsy Assay for Lung Cancer Detection
SAN DIEGO--(BUSINESS WIRE)--Highlighting that cancer is no longer considered a sterile disease, Greg Sepich-Poore, Ph.D., Chief Analytic Officer and Co-founder of Micronoma, the first biotech company offering early cancer detection with a microbiome-driven, multi-omics liquid biopsy, shared the company’s impressive diagnostic capabilities in a presentation at the American Association for Cancer Research’s (AACR) annual meeting in Orlando, Florida. The recent work adds to the growing body of eviFrost & Sullivan Lauds Micronoma with Award for Technology Innovation Leadership
SAN DIEGO--(BUSINESS WIRE)--Frost & Sullivan selected Micronoma, with a microbiome-driven liquid biopsy platform, for the Best Practices Technology Innovation Leadership AwardMicronoma Receives FDA Breakthrough Device Designation for OncobiotaLUNG, A Novel Liquid Biopsy Assay for Lung Carcinoma Detection
SAN DIEGO--(BUSINESS WIRE)--Micronoma, the first biotech company offering early cancer detection with a microbiome-driven liquid biopsy platform, announced today that its OncobiotaLUNG assay received the Breakthrough Device Designation from the Food and Drug Administration (FDA). As a result, Micronoma can expect continued guidance and prioritized reviews from the agency of its upcoming clinical trial and concomitant pre-market approval processes. The FDA based its Breakthrough Device decisionMicronoma to Provide Oncobiota Solution and Company Updates During JPM Life Science Conference Week 2023
SAN DIEGO--(BUSINESS WIRE)--Micronoma, the first biotech company offering early cancer detection using a microbiome-driven liquid biopsy platform, today announced that Sandrine Miller-Montgomery, Ph.D., Pharm.D., CEO and Co-founder of Micronoma will participate in J.P. Morgan Week in San Francisco, CA in January 2023. Miller-Montgomery will present company updates at the following events: Event: Biotech Showcase 2023: The Investor Conference for Innovators January 9-11, 2023, San Francisco, U.S
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Micronoma
Sign Up For FreeTo access detailed company insights
Founded in 2019 and headquartered in San Diego, California, Micronoma is a cancer-detection company that uses liquid biopsy technology to detect and predict cancers.... Read More
